BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 18952834)

  • 1. Hepatic stearoyl-CoA desaturase (SCD)-1 activity and diacylglycerol but not ceramide concentrations are increased in the nonalcoholic human fatty liver.
    Kotronen A; Seppänen-Laakso T; Westerbacka J; Kiviluoto T; Arola J; Ruskeepää AL; Oresic M; Yki-Järvinen H
    Diabetes; 2009 Jan; 58(1):203-8. PubMed ID: 18952834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between hepatic stearoyl-CoA desaturase-1 activity and mRNA expression with liver fat content in humans.
    Peter A; Cegan A; Wagner S; Elcnerova M; Königsrainer A; Königsrainer I; Häring HU; Schleicher ED; Stefan N
    Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E321-6. PubMed ID: 21045174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A lipidomic analysis of nonalcoholic fatty liver disease.
    Puri P; Baillie RA; Wiest MM; Mirshahi F; Choudhury J; Cheung O; Sargeant C; Contos MJ; Sanyal AJ
    Hepatology; 2007 Oct; 46(4):1081-90. PubMed ID: 17654743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of lipid and fatty acid composition of the liver, subcutaneous and intra-abdominal adipose tissue, and serum.
    Kotronen A; Seppänen-Laakso T; Westerbacka J; Kiviluoto T; Arola J; Ruskeepää AL; Yki-Järvinen H; Oresic M
    Obesity (Silver Spring); 2010 May; 18(5):937-44. PubMed ID: 19798063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stearoyl-CoA desaturase-1 deficiency reduces ceramide synthesis by downregulating serine palmitoyltransferase and increasing beta-oxidation in skeletal muscle.
    Dobrzyn A; Dobrzyn P; Lee SH; Miyazaki M; Cohen P; Asilmaz E; Hardie DG; Friedman JM; Ntambi JM
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E599-607. PubMed ID: 15562249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High hepatic SCD1 activity is associated with low liver fat content in healthy subjects under a lipogenic diet.
    Silbernagel G; Kovarova M; Cegan A; Machann J; Schick F; Lehmann R; Häring HU; Stefan N; Schleicher E; Fritsche A; Peter A
    J Clin Endocrinol Metab; 2012 Dec; 97(12):E2288-92. PubMed ID: 23015656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a high-throughput screening assay for stearoyl-CoA desaturase using rat liver microsomes, deuterium labeled stearoyl-CoA and mass spectrometry.
    Soulard P; McLaughlin M; Stevens J; Connolly B; Coli R; Wang L; Moore J; Kuo MS; LaMarr WA; Ozbal CC; Bhat BG
    Anal Chim Acta; 2008 Oct; 627(1):105-11. PubMed ID: 18790133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a novel LC/MS method to quantitate cellular stearoyl-CoA desaturase activity.
    Dillon R; Greig MJ; Bhat BG
    Anal Chim Acta; 2008 Oct; 627(1):99-104. PubMed ID: 18790132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity.
    Kolak M; Westerbacka J; Velagapudi VR; Wågsäter D; Yetukuri L; Makkonen J; Rissanen A; Häkkinen AM; Lindell M; Bergholm R; Hamsten A; Eriksson P; Fisher RM; Oresic M; Yki-Järvinen H
    Diabetes; 2007 Aug; 56(8):1960-8. PubMed ID: 17620421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical determinants and mortality predictability of stearoyl-CoA desaturase-1 activity indices in dialysis patients.
    Huang X; Stenvinkel P; Qureshi AR; Cederholm T; Bárány P; Heimbürger O; Lindholm B; Risérus U; Carrero JJ
    J Intern Med; 2013 Mar; 273(3):263-72. PubMed ID: 22897446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic iron and nonalcoholic fatty liver disease.
    Younossi ZM; Gramlich T; Bacon BR; Matteoni CA; Boparai N; O'Neill R; McCullough AJ
    Hepatology; 1999 Oct; 30(4):847-50. PubMed ID: 10498632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of hepatic desaturases in obesity-related metabolic disorders.
    Bjermo H; Risérus U
    Curr Opin Clin Nutr Metab Care; 2010 Nov; 13(6):703-8. PubMed ID: 20823776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma stearoyl-CoA desaturase indices: association with lifestyle, diet, and body composition.
    Vinknes KJ; Elshorbagy AK; Nurk E; Drevon CA; Gjesdal CG; Tell GS; Nygård O; Vollset SE; Refsum H
    Obesity (Silver Spring); 2013 Mar; 21(3):E294-302. PubMed ID: 23404690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of preestablished diet-induced fatty liver by oral fatty acid-bile acid conjugates in rodents.
    Leikin-Frenkel A; Goldiner I; Leikin-Gobbi D; Rosenberg R; Bonen H; Litvak A; Bernheim J; Konikoff FM; Gilat T
    Eur J Gastroenterol Hepatol; 2008 Dec; 20(12):1205-13. PubMed ID: 18989145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low hepatic stearoyl-CoA desaturase 1 activity is associated with fatty liver and insulin resistance in obese humans.
    Stefan N; Peter A; Cegan A; Staiger H; Machann J; Schick F; Claussen CD; Fritsche A; Häring HU; Schleicher E
    Diabetologia; 2008 Apr; 51(4):648-56. PubMed ID: 18286258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ lipidomic analysis of nonalcoholic fatty liver by cluster TOF-SIMS imaging.
    Debois D; Bralet MP; Le Naour F; Brunelle A; Laprévote O
    Anal Chem; 2009 Apr; 81(8):2823-31. PubMed ID: 19296690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of the hepatic fatty acid pool in peroxisomal 3-ketoacyl-CoA thiolase B-null mice exposed to the selective PPARalpha agonist Wy14,643.
    Arnauld S; Fidaleo M; Clémencet MC; Chevillard G; Athias A; Gresti J; Wanders RJ; Latruffe N; Nicolas-Francès V; Mandard S
    Biochimie; 2009; 91(11-12):1376-86. PubMed ID: 19772884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipidomics of hepatic lipogenesis inhibition by omega 3 fatty acids.
    Lamaziere A; Wolf C; Barbe U; Bausero P; Visioli F
    Prostaglandins Leukot Essent Fatty Acids; 2013 Feb; 88(2):149-54. PubMed ID: 23313470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects.
    Westerbacka J; Kolak M; Kiviluoto T; Arkkila P; Sirén J; Hamsten A; Fisher RM; Yki-Järvinen H
    Diabetes; 2007 Nov; 56(11):2759-65. PubMed ID: 17704301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum fatty acid composition and indices of stearoyl-CoA desaturase activity are associated with systemic inflammation: longitudinal analyses in middle-aged men.
    Petersson H; Basu S; Cederholm T; Risérus U
    Br J Nutr; 2008 Jun; 99(6):1186-9. PubMed ID: 18062827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.